Research location
Marquette
Michigan, United States
Advertisement
Research activity in Marquette
Michigan, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 75 trials and 88 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Marquette
75 linked trials · page 2 of 2Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation TherapyNCT00053898 · 2003-01-01 · 1 site observation
COMPLETED
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung CancerNCT00045162 · 2002-11-01 · 1 site observation
COMPLETED
InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) RegistryNCT00273182 · 2002-03-01 · 1 site observation
COMPLETED
Cognition in the Study of Tamoxifen and RaloxifeneNCT00687102 · 2001-10-01 · 1 site observation
COMPLETED
Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in SurgeryNCT00006470 · 2001-03-01 · 1 site observation
COMPLETED
External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerNCT00006365 · 2000-11-01 · 1 site observation
COMPLETED
S9925: Collecting and Storing Samples From Patients With Lung CancerNCT00920010 · 2000-09-01 · 1 site observation
COMPLETED
Iressa Expanded Access Program (EAP)NCT00034879 · 2000-08-01 · 1 site observation
COMPLETED
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerNCT00005044 · 2000-02-01 · 1 site observation
COMPLETED
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate CancerNCT00004054 · 2000-01-01 · 1 site observation
COMPLETED
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in SituNCT00003857 · 1999-12-01 · 1 site observation
COMPLETED
S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerNCT00004011 · 1999-10-01 · 1 site observation
COMPLETED
Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval StudyNCT01076361 · 1999-09-01 · 1 site observation
COMPLETED
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenNCT00003906 · 1999-05-01 · 1 site observation
COMPLETED
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung CancerNCT00003313 · 1998-09-01 · 1 site observation
COMPLETED
Brachytherapy in Treating Patients With Prostate CancerNCT00003312 · 1998-09-01 · 1 site observation
COMPLETED
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate CancerNCT00003162 · 1998-02-01 · 1 site observation
COMPLETED
Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung CancerNCT00005022 · 1998-02-01 · 1 site observation
COMPLETED
Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical ProstatectomyNCT00002874 · 1998-02-01 · 1 site observation
COMPLETED
Radiation Therapy in Treating Women With Stage I or Stage II Breast CancerNCT00002873 · 1997-05-01 · 1 site observation
COMPLETED
Model 4965 Post-Approval StudyNCT01076348 · 1996-09-01 · 1 site observation
COMPLETED
Radiation Therapy in Treating Patients With Non-small Cell Lung CancerNCT00002577 · 1995-07-01 · 1 site observation
COMPLETED
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerNCT00002597 · 1994-10-01 · 1 site observation
COMPLETED
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerNCT00002602 · 1994-05-01 · 1 site observation
COMPLETED
TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.NCT00245739 · 1 site observation
APPROVED_FOR_MARKETING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.